ALNYLAM PHARMACEUTICALS, INC. Other Nonoperating Income (Expense)
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Other Nonoperating Income (Expense) of $273.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-07-30
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $273.00K, a 96.92% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$3.36M.
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$74.15M.
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was $8.86M.
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2025 was $5.20M.
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2024 was -$180.62M.
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2023 was -$125.68M.
- ALNYLAM PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2022 was -$134.18M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $273.00K 10-Q · filed 2026-07-30 | -$4.02M 10-Q · filed 2026-07-30 | ||||||
| 2025-12-31 | -$3.36M derived: 10-K 12 month − 10-K 9 month · filed 2026-02-12 | -$77.51M derived: sum of 2 quarters · filed 2026-02-12 | -$68.65M derived: sum of 3 quarters · filed 2026-07-30 | $5.20M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | -$74.15M 10-Q · filed 2025-10-30 | -$65.29M derived: sum of 2 quarters · filed 2026-07-30 | $8.56M 10-K · filed 2026-02-12 | -$130.25M 10-Q · filed 2025-10-30 | -$136.95M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $8.86M 10-Q · filed 2026-07-30 | -$6.40M 10-Q · filed 2025-07-31 | $18.05M 10-Q · filed 2026-07-30 | -$56.10M 10-Q · filed 2025-07-31 | -$62.80M derived: sum of 3 quarters · filed 2026-07-30 | -$92.32M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $9.19M 10-K · filed 2026-02-12 | -$49.70M 10-Q · filed 2025-05-01 | -$71.66M derived: sum of 2 quarters · filed 2026-02-12 | -$101.18M derived: sum of 3 quarters · filed 2026-02-12 | -$156.89M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-12-31 | -$80.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$110.38M derived: sum of 2 quarters · filed 2026-02-12 | -$166.08M derived: sum of 3 quarters · filed 2026-02-12 | -$180.62M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | -$29.53M 10-Q · filed 2025-10-30 | -$85.23M derived: sum of 2 quarters · filed 2025-10-30 | -$99.78M 10-Q · filed 2025-10-30 | -$120.13M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | -$55.70M 10-Q · filed 2025-07-31 | -$70.25M 10-Q · filed 2025-07-31 | -$90.60M derived: sum of 3 quarters · filed 2026-02-12 | -$148.26M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | -$14.54M 10-Q · filed 2025-05-01 | -$34.90M derived: sum of 2 quarters · filed 2026-02-12 | -$92.55M derived: sum of 3 quarters · filed 2026-02-12 | -$127.97M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | -$20.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$78.01M derived: sum of 2 quarters · filed 2026-02-12 | -$113.43M derived: sum of 3 quarters · filed 2026-02-12 | -$125.68M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | -$57.66M 10-Q · filed 2024-10-31 | -$93.08M derived: sum of 2 quarters · filed 2024-10-31 | -$105.33M 10-Q · filed 2024-10-31 | -$107.90M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | -$35.42M 10-Q · filed 2024-08-01 | -$47.67M 10-Q · filed 2024-08-01 | -$50.24M derived: sum of 3 quarters · filed 2025-02-13 | -$88.30M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | -$12.26M 10-Q · filed 2024-05-02 | -$14.83M derived: sum of 2 quarters · filed 2025-02-13 | -$52.88M derived: sum of 3 quarters · filed 2025-02-13 | -$95.16M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$40.62M derived: sum of 2 quarters · filed 2025-02-13 | -$82.90M derived: sum of 3 quarters · filed 2025-02-13 | -$134.18M 10-K · filed 2025-02-13 | -$109.37M 10-K · filed 2023-02-23 | |||
| 2022-09-30 | -$38.05M 10-Q · filed 2023-11-02 | -$30.23M 10-Q · filed 2022-10-27 | -$80.33M derived: sum of 2 quarters · filed 2023-11-02 | -$131.60M 10-Q · filed 2023-11-02 | -$120.87M 10-Q · filed 2022-10-27 | -$162.11M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2022-06-30 | -$42.28M 10-Q · filed 2023-08-03 | -$40.38M 10-Q · filed 2022-07-28 | -$93.55M 10-Q · filed 2023-08-03 | -$90.64M 10-Q · filed 2022-07-28 | -$124.06M derived: sum of 3 quarters · filed 2024-02-15 | -$106.34M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2022-03-31 | -$51.27M 10-Q · filed 2023-05-04 | -$81.78M derived: sum of 2 quarters · filed 2024-02-15 | -$64.06M derived: sum of 3 quarters · filed 2024-02-15 | -$72.82M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | -$30.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$12.79M derived: sum of 2 quarters · filed 2024-02-15 | -$21.54M derived: sum of 3 quarters · filed 2024-02-15 | -$2.05M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $17.71M 10-Q · filed 2022-10-27 | $17.49M 10-Q · filed 2021-10-28 | $8.96M derived: sum of 2 quarters · filed 2022-10-27 | $28.45M 10-Q · filed 2022-10-27 | $27.37M 10-Q · filed 2021-10-28 | $17.86M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-06-30 | -$8.76M 10-Q · filed 2022-07-28 | -$9.16M 10-Q · filed 2021-08-03 | $10.74M 10-Q · filed 2022-07-28 | $9.88M 10-Q · filed 2021-08-03 | $146.00K derived: sum of 3 quarters · filed 2023-02-23 | -$448.00K derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-03-31 | $19.04M 10-Q · filed 2022-04-28 | $8.90M derived: sum of 2 quarters · filed 2023-02-23 | $8.31M derived: sum of 3 quarters · filed 2023-02-23 | $53.35M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$10.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$10.74M derived: sum of 2 quarters · filed 2023-02-23 | $34.30M derived: sum of 3 quarters · filed 2023-02-23 | $57.33M 10-K · filed 2023-02-23 | $45.52M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | -$594.00K 10-Q · filed 2021-10-28 | $44.45M derived: sum of 2 quarters · filed 2021-10-28 | $67.48M 10-Q · filed 2021-10-28 | $91.14M derived: sum of 4 quarters · filed 2022-02-10 | ||||
| 2020-06-30 | $45.04M 10-Q · filed 2021-08-03 | $68.07M 10-Q · filed 2021-08-03 | $91.73M derived: sum of 3 quarters · filed 2022-02-10 | $89.21M derived: sum of 4 quarters · filed 2022-02-10 | ||||
| 2020-03-31 | $23.03M 10-Q · filed 2021-04-29 | $46.69M derived: sum of 2 quarters · filed 2022-02-10 | $44.17M derived: sum of 3 quarters · filed 2022-02-10 | $43.72M derived: sum of 4 quarters · filed 2022-02-10 | ||||
| 2019-12-31 | $23.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $21.14M derived: sum of 2 quarters · filed 2022-02-10 | $20.69M derived: sum of 3 quarters · filed 2022-02-10 | $20.73M 10-K · filed 2022-02-10 | $11.31M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | -$2.52M 10-Q · filed 2020-11-05 | -$2.97M derived: sum of 2 quarters · filed 2020-11-05 | -$2.93M 10-Q · filed 2020-11-05 | $16.34M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | -$453.00K 10-Q · filed 2020-08-06 | -$410.00K 10-Q · filed 2020-08-06 | $18.86M derived: sum of 3 quarters · filed 2021-02-11 | $21.78M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $43.00K 10-Q · filed 2020-05-06 | $19.31M derived: sum of 2 quarters · filed 2021-02-11 | $22.24M derived: sum of 3 quarters · filed 2021-02-11 | $24.45M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $19.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $22.19M derived: sum of 2 quarters · filed 2021-02-11 | $24.40M derived: sum of 3 quarters · filed 2021-02-11 | $24.74M 10-K · filed 2021-02-11 | $4.17M 10-K · filed 2019-02-14 | |||
| 2018-09-30 | $2.92M 10-Q · filed 2019-10-31 | $5.13M derived: sum of 2 quarters · filed 2019-10-31 | $5.47M 10-Q · filed 2019-10-31 | $6.31M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $2.21M 10-Q · filed 2019-08-06 | $2.54M 10-Q · filed 2019-08-06 | $3.38M derived: sum of 3 quarters · filed 2020-02-13 | $2.95M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $335.00K 10-Q · filed 2019-05-02 | $1.18M derived: sum of 2 quarters · filed 2020-02-13 | $743.00K derived: sum of 3 quarters · filed 2020-02-13 | $220.00K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $841.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $408.00K derived: sum of 2 quarters · filed 2020-02-13 | -$115.00K derived: sum of 3 quarters · filed 2020-02-13 | -$3.02M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | -$433.00K 10-Q · filed 2018-11-07 | -$956.00K derived: sum of 2 quarters · filed 2018-11-07 | -$3.86M 10-Q · filed 2018-11-07 | -$3.56M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-06-30 | -$523.00K 10-Q · filed 2018-08-02 | -$3.43M 10-Q · filed 2018-08-02 | -$3.13M derived: sum of 3 quarters · filed 2019-02-14 | -$2.73M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-03-31 | -$2.91M 10-Q · filed 2018-05-04 | -$2.61M derived: sum of 2 quarters · filed 2019-02-14 | -$2.21M derived: sum of 3 quarters · filed 2019-02-14 | -$1.98M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2016-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $701.00K derived: sum of 2 quarters · filed 2019-02-14 | $930.00K derived: sum of 3 quarters · filed 2019-02-14 | $6.17M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $401.00K 10-Q · filed 2017-11-07 | $630.00K derived: sum of 2 quarters · filed 2017-11-07 | $5.87M 10-Q · filed 2017-11-07 | $6.05M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $229.00K 10-Q · filed 2017-08-09 | $5.47M 10-Q · filed 2017-08-09 | $5.64M derived: sum of 3 quarters · filed 2018-02-15 | $5.57M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $5.24M 10-Q · filed 2017-05-05 | $5.42M derived: sum of 2 quarters · filed 2018-02-15 | $5.34M derived: sum of 3 quarters · filed 2018-02-15 | $5.32M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $103.00K derived: sum of 2 quarters · filed 2018-02-15 | $76.00K derived: sum of 3 quarters · filed 2018-02-15 | $76.00K 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | -$72.00K 10-Q · filed 2016-11-03 | -$99.00K derived: sum of 2 quarters · filed 2016-11-03 | -$99.00K 10-Q · filed 2016-11-03 | |||||
| 2015-06-30 | -$27.00K 10-Q · filed 2016-08-04 | -$27.00K 10-Q · filed 2016-08-04 | ||||||
| 2014-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $1.98M derived: sum of 2 quarters · filed 2017-02-15 | $1.90M derived: sum of 3 quarters · filed 2017-02-15 | $1.82M 10-K · filed 2017-02-15 | ||||
| 2014-09-30 | $524.00K 10-Q · filed 2015-11-09 | $447.00K derived: sum of 2 quarters · filed 2015-11-09 | $365.00K 10-Q · filed 2015-11-09 | $336.00K derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | -$77.00K 10-Q · filed 2015-08-07 | -$159.00K 10-Q · filed 2015-08-07 | -$188.00K derived: sum of 3 quarters · filed 2016-02-12 | -$200.00K derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | -$82.00K 10-Q · filed 2015-05-08 | -$111.00K derived: sum of 2 quarters · filed 2016-02-12 | -$123.00K derived: sum of 3 quarters · filed 2016-02-12 | -$134.00K derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$41.00K derived: sum of 2 quarters · filed 2016-02-12 | -$52.00K derived: sum of 3 quarters · filed 2016-02-12 | -$47.00K 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | -$12.00K 10-Q · filed 2014-11-06 | -$23.00K derived: sum of 2 quarters · filed 2014-11-06 | -$18.00K 10-Q · filed 2014-11-06 | $146.00K derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | -$11.00K 10-Q · filed 2014-08-08 | -$6.00K 10-Q · filed 2014-08-08 | $158.00K derived: sum of 3 quarters · filed 2015-02-13 | $155.00K derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $5.00K 10-Q · filed 2014-05-09 | $169.00K derived: sum of 2 quarters · filed 2015-02-13 | $166.00K derived: sum of 3 quarters · filed 2015-02-13 | $145.00K derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $161.00K derived: sum of 2 quarters · filed 2015-02-13 | $140.00K derived: sum of 3 quarters · filed 2015-02-13 | $331.00K 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | -$3.00K 10-Q · filed 2013-11-07 | -$24.00K derived: sum of 2 quarters · filed 2013-11-07 | $167.00K 10-Q · filed 2013-11-07 | $168.00K derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-06-30 | -$21.00K 10-Q · filed 2013-08-09 | $170.00K 10-Q · filed 2013-08-09 | $171.00K derived: sum of 3 quarters · filed 2014-02-20 | -$426.00K derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-03-31 | $191.00K 10-Q · filed 2013-05-07 | $192.00K derived: sum of 2 quarters · filed 2014-02-20 | -$405.00K derived: sum of 3 quarters · filed 2014-02-20 | -$421.00K derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2011-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$596.00K derived: sum of 2 quarters · filed 2014-02-20 | -$612.00K derived: sum of 3 quarters · filed 2014-02-20 | -$531.00K 10-K · filed 2014-02-20 | ||||
| 2011-09-30 | -$597.00K 10-Q · filed 2012-11-05 | -$613.00K derived: sum of 2 quarters · filed 2012-11-05 | -$532.00K 10-Q · filed 2012-11-05 | $1.40M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-06-30 | -$16.00K 10-Q · filed 2012-08-08 | $65.00K 10-Q · filed 2012-08-08 | $2.00M derived: sum of 3 quarters · filed 2013-02-19 | $2.02M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-03-31 | $81.00K 10-Q · filed 2012-05-03 | $2.01M derived: sum of 2 quarters · filed 2013-02-19 | $2.03M derived: sum of 3 quarters · filed 2013-02-19 | $2.07M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2010-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $1.95M derived: sum of 2 quarters · filed 2013-02-19 | $1.99M derived: sum of 3 quarters · filed 2013-02-19 | $1.98M 10-K · filed 2013-02-19 | $6.40M 10-K · filed 2011-02-18 | |||
| 2010-09-30 | $20.00K 10-Q · filed 2011-11-03 | $63.00K derived: sum of 2 quarters · filed 2011-11-03 | $52.00K 10-Q · filed 2011-11-03 | $536.00K derived: sum of 4 quarters · filed 2012-02-13 | ||||
| 2010-06-30 | $43.00K 10-Q · filed 2011-08-03 | $32.00K 10-Q · filed 2011-08-03 | $516.00K derived: sum of 3 quarters · filed 2012-02-13 | $506.00K derived: sum of 4 quarters · filed 2012-02-13 | ||||
| 2010-03-31 | -$11.00K 10-Q · filed 2011-05-05 | $473.00K derived: sum of 2 quarters · filed 2012-02-13 | $463.00K derived: sum of 3 quarters · filed 2012-02-13 | $439.00K derived: sum of 4 quarters · filed 2012-02-13 | ||||
| 2009-12-31 | $484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $474.00K derived: sum of 2 quarters · filed 2012-02-13 | $450.00K derived: sum of 3 quarters · filed 2012-02-13 | $628.00K 10-K · filed 2012-02-13 | ||||
| 2009-09-30 | -$10.00K 10-Q · filed 2010-11-04 | -$34.00K derived: sum of 2 quarters · filed 2010-11-04 | $144.00K 10-Q · filed 2010-11-04 | |||||
| 2009-06-30 | -$24.00K 10-Q · filed 2010-08-05 | $154.00K 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | -$1.95M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |